BARCLAYS PLC

Position in VSTM — Verastem, Inc.

CIK 312069 LONDON, X0

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$478,590

-$1,079,653 QoQ

Shares Held

90,300

-55.3% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. VSTM ranks #155 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$478,590	90,300	-55.3%	Shares	Defined	2026-05-15
2025-12-31	$1,558,243	201,845	+19.9%	Shares	Sole	2026-02-13
2025-09-30	$1,486,750	168,375	-13.0%	Shares	Sole	2026-03-31
2025-06-30	$803,618	193,643	+359.4%	Shares	Sole	2026-02-27
2025-03-31	$254,152	42,148	-31.4%	Shares	Sole	2026-03-17
2024-12-31	$317,670	61,445	+10.3%	Shares	Sole	2026-03-19
2024-09-30	$166,566	55,708	+546.7%	Shares	Sole	2026-03-31
2024-06-30	$25,669	8,614	-72.3%	Shares	Sole	2026-03-23
2024-03-31	$366,519	31,061	+2827.5%	Shares	Sole	2026-03-24
2023-12-31	$8,636	1,061	-78.1%	Shares	Sole	2026-03-24
2023-09-30	$39,406	4,847	-81.4%	Shares	Sole	2026-03-26
2023-06-30	$193,893	26,061	—	Shares	Sole	2026-03-27
No filing history on record for this holder in this stock.